Citigroup’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $790 | Sell |
|
|||||
|
2025
Q1 | $61.6K | Sell |
|
|||||
|
2024
Q4 | $158K | Buy |
|
|||||
|
2024
Q3 | $2.81K | Sell |
|
|||||
|
2024
Q2 | $8.84K | Sell |
|
|||||
|
2024
Q1 | $21.2K | Buy |
|
|||||
|
2023
Q4 | $15.5K | Buy |
|
|||||
|
2023
Q3 | $1.51K | Sell |
|
|||||
|
2023
Q2 | $59.8K | Sell |
|
|||||
|
2023
Q1 | $1.08M | Buy |
|
|||||
|
2022
Q4 | $1.07M | Sell |
|
|||||
|
2022
Q3 | $1.95M | Buy |
|
|||||
|
2022
Q2 | $1.44M | Buy |
|
|||||
|
2022
Q1 | $730K | Sell |
|
|||||
|
2021
Q4 | $2.73M | Buy |
|
|||||
|
2021
Q3 | $2.08M | Sell |
|
|||||
|
2021
Q2 | $5.37M | Buy |
|
|||||
|
2021
Q1 | $5.47M | Buy |
|
|||||
|
2020
Q4 | $2.24M | Sell |
|
|||||
|
2020
Q3 | $1.38M | Sell |
|
|||||
|
2020
Q2 | $2.29M | Buy |
|
|||||
|
2020
Q1 | $1.52M | Buy |
|
|||||
|
2019
Q4 | $1.32M | Sell |
|
|||||
|
2019
Q3 | $2.2M | Buy |
|
|||||
|
2019
Q2 | $1.53M | Buy |
|
|||||
|
2019
Q1 | $882K | Sell |
|
|||||
|
2018
Q4 | $4.94M | Buy |
|
|||||
|
2018
Q3 | $1.74M | Sell |
|
|||||
|
2018
Q2 | $2.58M | Buy |
|
|||||
|
2018
Q1 | $2.35M | Sell |
|
|||||
|
2017
Q4 | $2.6M | Buy |
|
|||||
|
2017
Q3 | $891K | Buy |
|
|||||
|
2017
Q2 | $93K | Buy |
|
|||||
|
2017
Q1 | $35K | Sell |
|
|||||
|
2016
Q4 | $87K | Buy |
|
|||||
|
2016
Q3 | $69K | Buy |
|
|||||
|
2016
Q2 | $62K | Sell |
|
|||||
|
2016
Q1 | $327K | Buy |
|
|||||
|
2015
Q4 | $149K | Sell |
|
|||||
|
2015
Q3 | $450K | Buy |
|
|||||
|
2015
Q2 | $253K | Sell |
|
|||||
|
2015
Q1 | $439K | Sell |
|
|||||
|
2014
Q4 | $638K | Buy |
|
|||||
|
2014
Q3 | $201K | Buy |
|
|||||
|
2014
Q2 | $192K | Sell |
|
|||||
|
2014
Q1 | $334K | Sell |
|
|||||
|
2013
Q4 | $516K | Buy |
|
|||||
|
2013
Q3 | $156K | Buy |
|
|||||
|
2013
Q2 | $32K | Buy |
|